PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Alfaro, A.J. ; Dittner, C.* ; Becker, J.* ; Loft, A. ; Mhamane, A. ; Maida, A. ; Georgiadi, A. ; Tsokanos, F.-F. ; Klepac, K. ; Molocea, C.-E. ; El-Merahbi, R. ; Motzler, K. ; Geppert, J. ; Karikari, R.A. ; Szendrödi, J.* ; Feuchtinger, A. ; Hofmann, S.M. ; Karaca, S.* ; Urlaub, H.* ; Berriel Diaz, M. ; Melchior, F.* ; Herzig, S.

Fasting-sensitive SUMO-switch on Prox1 controls hepatic cholesterol metabolism.

EMBO Rep. 24:e55981 (2023)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Accumulation of excess nutrients hampers proper liver function and is linked to nonalcoholic fatty liver disease (NAFLD) in obesity. However, the signals responsible for an impaired adaptation of hepatocytes to obesogenic dietary cues remain still largely unknown. Post-translational modification by the small ubiquitin-like modifier (SUMO) allows for a dynamic regulation of numerous processes including transcriptional reprogramming. We demonstrate that specific SUMOylation of transcription factor Prox1 represents a nutrient-sensitive determinant of hepatic fasting metabolism. Prox1 is highly SUMOylated on lysine 556 in the liver of ad libitum and refed mice, while this modification is abolished upon fasting. In the context of diet-induced obesity, Prox1 SUMOylation becomes less sensitive to fasting cues. The hepatocyte-selective knock-in of a SUMOylation-deficient Prox1 mutant into mice fed a high-fat/high-fructose diet leads to a reduction of systemic cholesterol levels, associated with the induction of liver bile acid detoxifying pathways during fasting. The generation of tools to maintain the nutrient-sensitive SUMO-switch on Prox1 may thus contribute to the development of "fasting-based" approaches for the preservation of metabolic health.
Impact Factor
Scopus SNIP
Altmetric
7.700
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Bile Acids ; Cholesterol ; Liver ; Prox1 ; Sumoylation; Homeobox Protein Prox1; Bile-acid; Nuclear Receptors; Mammalian-cells; Sumoylation; Liver; Transcription; Mechanisms; Expression; Corepressor
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 1469-221X
e-ISSN 1469-3178
Zeitschrift EMBO Reports
Quellenangaben Band: 24, Heft: 10, Seiten: , Artikelnummer: e55981 Supplement: ,
Verlag EMBO Press
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)
Research Unit Analytical Pathology (AAP)
Institute of Diabetes and Regeneration Research (IDR)
POF Topic(s) 90000 - German Center for Diabetes Research
30205 - Bioengineering and Digital Health
30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP-Element(e) G-501900-251
G-501900-252
G-501900-254
G-501900-257
G-500390-001
G-502390-001
G-501900-253
Förderungen Open Access funding enabled and organized by Projekt DEAL
DKFZ-ZMBH Alliance
Edith-Haberland-Wagner Stiftung
DOI 10.15252/embr.202255981
WOS ID 001044881800001
Scopus ID 85167443184
PubMed ID 37560809
Erfassungsdatum 2023-10-06
[➜Korrektur melden]